Agile plans to price IPO of 9,166,667 common shares at $6.00 per share

RBC Capital Markets, William Blair are the joint bookrunning managers

By Devika Patel

Knoxville, Tenn., May 22 - Agile Therapeutics, Inc. will sell 9,166,667 common shares in its initial public offering with a 30-day greenshoe option of 1,375,000 additional shares, according to a Form S-1/A filed Thursday with the Securities and Exchange Commission. The deal was announced March 17.

The shares will be sold at a price expected to be $6.00 per share.

RBC Capital Markets and William Blair are the joint bookrunning managers. Cantor Fitzgerald & Co. and Janney Montgomery Scott are the co-managers.

Proceeds will be used for clinical trials, equipment validation and expansion of Corium's manufacturing capabilities, development of the company's product candidate pipeline, making scheduled principal and interest payments on the company's term loan with Oxford Finance, LLC, working capital and general corporate purposes.

The women's health specialty pharmaceutical company is based in Princeton, N.J. The company intends to list its common stock on the Nasdaq under the symbol "AGRX."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.